Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$245,074,000
New position
Shares Held
18,100,000
first reported quarter
Ownership
6.89%
of shares outstanding
% of Portfolio
1.99%
of 13F equity value
Holder Rank
#2
of 626 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pentwater Capital Management LP holds $245,074,000 across 1 Drug Manufacturers - General name. OGN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OGN |
Organon & Co.
This page
|
18,100,000 | $245,074,000 |
All Filings in OGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $245,074,000 | 18,100,000 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $245,074,000 | 18,100,000 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||